Baxter Licenses Platelet System To Haemonetics, Anticipates 2003 Approval
Baxter expects FDA approval by mid-2003 for its Intercept platelet blood screening system, licensed to Haemonetics in a deal announced Dec. 10
Baxter expects FDA approval by mid-2003 for its Intercept platelet blood screening system, licensed to Haemonetics in a deal announced Dec. 10